l carnitine tmao koeth 2013 nature medicine γ–Butyrobetaine is a pro-atherogenic intermediate in gut microbial metabolism of L-carnitine to Trimethylamine/Trimethylamine-N-Oxide as a Key Between
Trimethylamine Trimethylamine N Oxide as a Key Between Diet and Cardiovascular Diseases Cardiovascular Toxicology Springer Nature Link Emerging role of trimethylamine N oxide (TMAO) in colorectal cancer Applied Microbiology and Biotechnology Springer Nature Link Intestinal microbiota metabolism of l carnitine, a nutrient in red meat, promotes atherosclerosis Nature Medicine Comparison of short term and long term effects of peroral L carnitine intake: clinical implications of elevated TMAO levels in cardiovascular complications Dietary allicin reduces transformation of L carnitine to TMAO through impact on gut microbiota ScienceDirect
Pay in 4 interest-free payments of $7.01 Learn more
Shipping Estimate
USA
- USA
- CAN
- USA
- CAN
Ships within 48 hours · Estimated delivery Aug 1 - Aug 6




